inhalation oldest modes drug delivery currently receiving renewed attention prior NUMBER aerosolized therapeutics delivered systems relied chlorofluorocarbon propellant systems subsequent ban nonmedical uses inert gases stimulated pharmaceutical companies investigate propellant systems hydrofluoroalkanes effective instances change propellant required reformulation drugs delivered cases bioequivalence achieved lower doses reduced toxicity pressurized inhalers pmdis used deliver types inhaled therapeutics 1960s major limitation drug delivery effectiveness affected patient factors including coordination difficulties problems related breathing breath holding patients airway disease inhalers developed deliver powdered formulations drugs bronchodilators drugs treatment asthma copd eventually proteins peptides recombinant products gene therapeutics devices proven efficient pmdis clinical trials cases deliver greater drug lungs percentages emitted dose deposited lungs range NUMBER NUMBER current generation devices finally liquid inhalers development drug deposition lung devices currently tested ranges NUMBER NUMBER emitted dose choice delivery depends effective dose drug deposition patient ability patient acceptance cost patient education correct use device essential maximize therapeutic benefit metered dose dry powder anti inflammatory metered dose